A Phase 3, Open-Label, Randomized, Allopurinol-Controlled Study to Assess the Long-Term Safety of Oral Febuxostat in Subjects With Gout
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00002439/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the long-term safety of febuxostat, once daily (QD), compared to allopurinol in reducing serum urate levels in subjects with gout.
提供机构：
Vivli
创建时间：
2018-10-27
